Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer
19. Dezember 2024 07:00 ET
|
Lexeo Therapeutics
Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer